Healthcare technology solutions are popping up everywhere. AI, ML, and other automation solutions are more prevalent than ever. How your […]
Event Categorie: Open to Public
2023 Policy Outlook for the Life Sciences
Join Marc Samuels and Lindsay Bealor Greenleaf, from ADVI Health. Two of Washington, DC’s most prominent health and life science policy […]
A Perspective from J&J Innovation: Strategic Thinking on Venture Investments Today and Into the Future?
Tamir Meiri will cover how Johnson & Johnson Venture Investments invests and supports globally to bring strategic value to companies […]
Effective Pitching for Early Stage Companies, Strategies for Success and Pitfalls to Avoid
Jared Sorin, co-leader of the Emerging Companies and Venture Capital practice group & Adam Schoen, Partner at Brown Rudnick, will […]
The Real Opportunity for Digital & Technology in Healthcare (Oliver Wyman’s Team)
Healthcare organizations from all corners are competing to leverage flexible technology infrastructure to rapidly push out offerings that meet consumer […]
Introduction to Software for Medical Devices in Early R&D Phases
Developing software for medical devices is vastly different than developing other commercial software. In this talk, we will explore how software […]
Regulatory 101: An Insider’s Perspective on Navigating the FDA Regulations Surrounding Digital Health & Devices
Interested in what makes a product salable and approvable? Interested in an insider’s view on what gets your device approved at FDA? Or how to navigate the regulations and use them to your advantage? How will recent developments to the United States Food and Drug Administration regulations impact your healthtech business? Whether you’re a CEO, entrepreneur, investor, clinician, or a professional in the general industry, join us as Neil Di Spirito gives us an insider’s perspective and breaks down what digital health and device companies should know about FDA regulations.